BioVie Inc. Accounts Payable and Accrued Liabilities, Noncurrent
BioVie Inc. (BIVI) had Accounts Payable and Accrued Liabilities, Noncurrent of $173.33 thousand as of 2017-09-30, per its 10-Q filed 2017-11-08.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:AccountsPayableAndAccruedLiabilitiesNoncurrent · last filed 2017-11-08
- 2017-09-30: Accounts Payable and Accrued Liabilities, Noncurrent $173.33K.
- 2017-06-30: Accounts Payable and Accrued Liabilities, Noncurrent $173.33K.
| Period end | Accounts Payable and Accrued Liabilities, Noncurrent |
|---|---|
| 2017-09-30 | $173.33K 10-Q · filed 2017-11-08 |
| 2017-06-30 | $173.33K 10-Q · filed 2017-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |